Blackstone (BX) encountered mixed market sentiments recently. Despite surpassing earnings expectations and revealing a 48% increase in distributable earnings for Q3, the company's stock experienced a downswing due to a profit miss. Several financial institutions, including JP Morgan, Barclays, TD Cowen, and Piper Sandler, lowered their price target for Blackstone. However, Morgan Stanley increased theirs to $215. In significant developments, Blackstone invested $705 Million in India's Federal Bank, making it the largest shareholder, and is considering bidding for Optum's UK Operations. Most notably, it has entered a significant $18.3 billion deal to take medtech firm Hologic private, joining forces with TPG. It also aimed to expand its retirement access to private market investments, revealing a strategic push into the retirement savings market. While valuation concerns are being debated within the investor community, Blackstone's record AUM and strong earnings growth were visual highlights. Yet, sales were reported below analyst estimates for Q3 earnings.
Blackstone BX News Analytics from Wed, 06 Aug 2025 07:00:00 GMT to Sat, 25 Oct 2025 21:19:11 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -6
